Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesAdministrative/Operational PolicyHumana prior auth policy update (SC) | OpenPayer
    Ask Trek AI about this page
    CurrentHumanaPolicy N/A

    Humana Dual Integrated South Carolina prior authorization and notification list (medications and administered services)

    Customize your policy alerts

    Sign up for all Humana policy alerts

    Know when Humana releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Governs prior authorization and notification requirements for medications (administered in-office, outpatient or home) and certain services for Humana Dual Integrated (HMO D-SNP) members in South Carolina; affects participating providers, delegated networks, and pharmacies that supply preferred medications.

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    Policy Summary
    PayerHumana
    PolicyHumana Dual Integrated South Carolina prior authorization and notification list (medications and administered services)
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateJul 1, 2026
    Next Review DateN/A
    Key ActionObtain prior authorization before administering listed medications using CoverMyMeds, phone (866-461-7273, TTY 711), or fax (888-447-3430).
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    20+listed medications in excerpt
    90+listed medications & biologics (partial)
    3PA initiation methods
    866-461-7273PA phone
    step therapystep therapy noted
    special handlingtransplant routing

    Coverage and Prior Authorization Criteria

    General coverage criteria

    Services and medications on this list require prior authorization and must meet Medicare/CMS coverage guidelines and medical necessity; step therapy and other operational constraints may apply as indicated.

    Prior authorization (preauthorization/precertification) is required for medications listed that are administered in office, clinic, outpatient or home settings before being provided or administered.
    Services must be provided in accordance with Medicare coverage guidelines established by CMS and must be medically necessary.
    Investigational and experimental procedures and devices are usually not covered; consult the patient's Evidence of Coverage or Humana for confirmation of coverage.
    Step therapy may apply where indicated; entries marked with the step therapy indicator require trial of a Humana-preferred drug as part of preauthorization (see Part B Step Therapy PDL).

    Refer to Humana's Part B Step Therapy Preferred Drug List for cross-benefit step therapy details and preferred drug designations.

    Active course of treatment exception: Humana does not require prior authorization for basic Medicare benefits during the first 90 days of a new member's enrollment for active courses of treatment started prior to enrollment.

    Prior authorization and notification requirements (medications/HCPCS)

    Prior authorization or notification is required for the medications and administered services listed; entries include billing code mappings and special handling annotations.

    Prior authorization or notification must be obtained for listed medications as indicated in the prior authorization and notification list.
    Each medication entry pairs brand and generic names with billing codes (HCPCS/J/C9399/J3490/J3590, etc.) to guide claims and authorization requests.
    Annotations and special handling: '*' = new preauthorization requirement; '†' = new-to-market drug; '‡' = shared HCPCS/NOC codes require corresponding NDC on all claims; '**' = step therapy required through a Humana-preferred drug; '††' = items routed to Humana National Transplant Network for review (with specified fax/phone/email submission options).
    Up to six diagnosis codes may be submitted per authorization request as part of documentation requirements for PA processing.

    Medication prior authorization entries (sample)

    Examples of medication entries show brand/generic names paired with billing codes and entry-level notes such as step therapy or transplant routing.

    Pyzchiva IV (ustekinumab-ttwe) — Billing code: Q9997; marked with '**' indicating step therapy may be required.
    Qalsody (tofersen) — Billing code: J1304; PA/notification required per list entry.
    Rituxan Hycela (rituximab; hyaluronidase human) — Billing code: J9311; marked with '**' indicating step therapy may apply.
    Remicade (infliximab) — Billing code: J1745; listed as requiring prior authorization/notification.
    Ruxience (rituximab-pvvr) — Billing code: Q5119; entry indicates prior authorization/notification required.

    Processing rules and special routing

    Operational, billing and routing requirements that affect processing of prior authorizations and claims.

    Shared HCPCS and not otherwise classified (NOC/C9399/J3490/J3590) codes (marked with '‡') require a corresponding National Drug Code (NDC) to be billed on all claims.
    Step therapy indicator ('**'): when present, prior authorization requires trials with a Humana-preferred drug prior to approval.
    Transplant-related items (marked '††') are reviewed by the Humana National Transplant Network; submission channels include fax (502-508-9300), phone (866-421-5663, Mon–Fri 7 a.m.–7 p.m. Central) and email (transplant@humana.com).

    Route transplant-related PA requests to the Humana National Transplant Network per the contact details provided.

    Medication prior authorization/notification entries (excerpt)

    Additional medication entries from the list that include billing codes and annotation flags (new requirement, step therapy, NDC billing requirement, transplant review).

    Vyvgart IV — Billing code: J9332; listed as requiring prior authorization/notification.
    Vyxeos — Billing code: J9153; example entry indicating PA/notification requirement.
    Xembify — Billing code: J1558; marked with '*' indicating new preauthorization requirement.
    Advate and other blood-clotting factors — examples include J7192, J7207, J7210; many immune globulin and clotting factor entries are marked '‡' indicating NDC billing requirement on claims.
    Annotation key reminder: '*' = new preauthorization requirement; '†' = new-to-market drug; '‡' = HCPCS/NOC codes require NDC on claims; '**' = step therapy required through a Humana-preferred drug; '††' = reviewed by Humana National Transplant Network.

    Billing Codes and Coding Rules

    Sample medication HCPCS/CPT/alpha codes from listHCPCSCovered
    Q2055Abecma intravenous suspension ††
    J9264Abraxane ** ‡
    J3262Actemra IV **
    Additional example billing codesHCPCSCovered
    J9035Avastin (bevacizumab) - auth required for Oncology/Chemo use
    J3145Aveed (testosterone undecanoate)
    Examples of HCPCS/J-codes listedHCPCSCovered
    J0178Eylea (aflibercept)
    J1305Evkeeza (evinacumab-dgnb)
    J1745Infliximab
    Examples of billing codes in excerptmixed
    Q9997Pyzchiva IV (ustekinumab-ttwe) - billing code listed
    J1304Qalsody (tofersen) - billing code listed
    J9311Rituxan Hycela (rituximab; hyaluronidase human) - billing code listed
    Additional billing codesmixed
    J3358Stelara IV (ustekinumab) - billing code listed
    J1301Billing code listed (example from list)
    Selected example HCPCS/J-codes from listHCPCS
    J9332Vyvgart IV
    J9153Vyxeos (daunorubicin/cytarabine)
    Blood-clotting factors HCPCS codes (examples)HCPCS
    J7192Advate / Kogenate FS (antihemophilic factor variants)
    J7207Adynovate
    J7210Afstyla
    Diagnosis code limit per authorization
    Diagnosis codes allowedUp to 6 diagnosis codes may be submitted per prior authorization request
    Why it mattersInclude all relevant ICD diagnoses (up to 6) to ensure accurate medical necessity review
    Where specifiedRequirement noted in documentation requirements and PA submission instructions
    NDC requirement for shared HCPCS/NOC codes
    NDC billing requirementAll shared HCPCS and not otherwise classified (NOC) codes require a corresponding National Drug Code (NDC) to be billed on all claims

    Provider Requirements, Submission Methods, and Documentation

    Prior Authorization

    Prior Authorization Required

    Providers must obtain prior authorization for medications and services listed for Humana Dual Integrated (HMO D-SNP) South Carolina members before administration, except where specific exceptions apply (for example, emergency care or active course of treatment protections described elsewhere). Failure to obtain required prior authorization may result in financial penalties to the practice, reduced benefits to the patient per the provider contract and Evidence of Coverage, and retrospective medical necessity review and claim denials.

    • Prior authorization methods: Online via CoverMyMeds (http://www.covermymeds.com/), by phone at 866-461-7273 (TTY: 711), Monday–Friday, 8 a.m.–11 p.m. Eastern time, or by fax to 888-447-3430. Request forms are available on Humana's prior authorization for professionally administered drugs website.
    • Advance coverage determinations (ACDs) for investigational or limited-benefit services or medications may be requested by phone at 866-461-7273 (TTY: 711) or by fax to 888-447-3430 to confirm payment prior to providing the service.
    • Transplant-related preauthorization requests are reviewed by the Humana National Transplant Network and may be submitted by fax to 502-508-9300, by phone at 866-421-5663, Monday–Friday, 7 a.m.–7 p.m. Central time, or by email to transplant@humana.com.
    • To prevent disruption of care, Humana does not require prior authorization for basic Medicare benefits during the first 90 days of a new member's enrollment for active courses of treatment that started prior to enrollment. Include appropriate modifier per Humana's Medicare Advantage Payment Policy (CP2023011) or medical records showing active course of treatment when submitting claims.

    Definitions and Annotation Keys

    Prior authorization — definition
    DefinitionPrior authorization (also called preauthorization or precertification) is a process requiring providers to obtain advance approval from the plan to determine whether an item or service will be covered
    ScopeApplies to medications delivered in office, clinic, outpatient or home settings and certain services listed in the document
    Coverage standardServices must meet Medicare/CMS coverage guidelines and be medically necessary
    Active course of treatment exception
    Exception summaryHumana does not require prior authorization for basic Medicare benefits during the first 90 days of a new member's enrollment for active courses of treatment that started prior to enrollment
    Documentation guidance
    Policy Summary
    PayerHumana
    PolicyHumana Dual Integrated South Carolina prior authorization and notification list (medications and administered services)
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateJul 1, 2026
    Next Review DateN/A
    Key ActionObtain prior authorization before administering listed medications using CoverMyMeds, phone (866-461-7273, TTY 711), or fax (888-447-3430).
    SourceLink
    On This Page
    Coverage and Prior Authorization CriteriaBilling Codes and Coding RulesProvider Requirements, Submission Methods, and DocumentationDefinitions and Annotation Keys
    Notation usedMarked with '‡' in the medication list to indicate the NDC requirement
    Impact on claimsFailure to include the corresponding NDC for shared HCPCS/NOC codes may affect claim payment processing
  1. All shared HCPCS and not otherwise classified (NOC) codes (marked ‡) require the corresponding NDC to be billed on all claims.
  2. Documentation Required

    Documentation Requirements

    When requesting prior authorization or an advance coverage determination, submit complete documentation to expedite the review. Humana may request additional clinical information if needed.

    • Patient name, date of birth and Humana member ID number
    • Date of actual service or hospital admission
    • HCPCS code(s) and diagnosis codes (primary and secondary) — up to 6 diagnosis codes per authorization request
    • Service location (inpatient: acute hospital, skilled nursing, hospice; outpatient: telehealth, office, home, off-campus outpatient hospital, on-campus outpatient hospital, ambulatory surgery center)
    • Tax Identification Number (TIN) and National Provider Identifier (NPI) of the facility where service is rendered, and TIN and NPI of the provider performing the service
    • Caller/requester name and phone number and attending provider's phone number
    • Relevant clinical information and supporting medical records
    Note

    Medication List Format and Legends

    Medication list entries use a consistent format and legends so providers can identify the brand name, generic name, and required billing codes and note any special entry flags.

    • Column 1: Brand medication name
    • Column 2: Generic medication name
    • Column 3: Billing codes (HCPCS/CPT/NDC guidance as applicable)
    • Legend and entry symbols: see Annotation Key block for symbol meanings
    • Each medication entry includes the identifiers necessary for submission (brand, generic, billing codes). For HCPCS/NOC entries marked with ‡, the corresponding NDC must be billed on all claims.
    Prior Authorization

    Prior Authorization Submission Methods

    General submission methods and operational notes for prior authorization requests and notifications.

    • Access fax forms to request preauthorization or provide notification via Humana's provider website (forms referenced throughout the medication list).
    • Standard submission options: CoverMyMeds, phone 866-461-7273 (TTY: 711), or fax 888-447-3430.
    • Include all required identifiers (see Documentation Requirements) with each request; submitting all relevant clinical information at initial request expedites determinations.
    • Entries marked with step therapy indicator (**) will require documentation of trial and failure (or contraindication) of a Humana-preferred drug as part of the preauthorization.
    • Services provided without required prior authorization may be subject to retrospective review and denial; always verify benefit and PA requirements prior to providing the service.
    Note

    How to Request Prior Authorization / Notification (HMO D-SNP)

    Specific submission guidance for Humana Dual Integrated (HMO D-SNP) South Carolina members and note on accessing forms.

    • Humana Dual Integrated (HMO D-SNP) South Carolina: access the fax forms to request preauthorization or provide notification using links on Humana's provider site where indicated throughout the medication list.
    • When submitting for HMO D-SNP members, include the plan/member identifiers and follow the same phone/fax/online channels listed above.
    Note

    Annotation Key for List Entries

    Annotation key — symbols used in the medication list and their meanings. Consolidated to avoid duplication and to ensure every symbol used in the list is defined.

    • * New preauthorization requirement
    • † New-to-market drug addition
    • ‡ All shared HCPCS codes and not otherwise classified (NOC) codes require a corresponding National Drug Code (NDC) to be billed on all claims
    • ** Step therapy required — prior authorization requires documentation of trial with a Humana-preferred drug (or documentation of contraindication/intolerance)
    • †† Transplant review — preauthorization requests will be reviewed by the Humana National Transplant Network (fax: 502-508-9300; phone: 866-421-5663, Mon–Fri 7 a.m.–7 p.m. CT; email: transplant@humana.com)
    To ensure appropriate claim payment, include the modifier per Humana's Medicare Advantage Payment Policy or medical records showing the member is in an active course of treatment
    Humana reviewHumana may still review services furnished during an active course of treatment against permissible coverage criteria when determining payment
    HCPCS/NDC billing requirement
    Billing requirementShared HCPCS and not otherwise classified (NOC) codes require a corresponding NDC to be billed on claims
    List annotationSuch codes are marked with '‡' in the medication list to indicate the NDC requirement
    Examples locationSee medication list entries and coding sections where '‡' appears next to agents and billing codes
    Step therapy note
    Meaning of '**'Entries marked with '**' indicate step therapy is required through a Humana-preferred drug as part of preauthorization
    Operational impactPrior authorization for '**'-marked drugs generally requires documented trials of a Humana-preferred agent before approval
    ReferenceStep therapy indicator noted in medication list legends and submission instructions
    Step therapy required (marked with **)
    Step therapy requirement'**' indicates step therapy required through a Humana-preferred drug as part of preauthorization
    Where shownMarked '**' next to medication names in the PA/notification list
    ImplicationPA approval may depend on prior use/trial of preferred alternatives per Humana's Step Therapy policy
    NDC billing requirement for shared HCPCS/NOC codes
    NDC requirement restatedAll shared HCPCS codes and not otherwise classified codes (marked with '‡') require a corresponding National Drug Code to be billed on all claims
    Where annotatedThe '‡' symbol appears in the medication list legends and next to affected entries
    Claims impactInclude the appropriate NDC on claims to support payment for agents billed with shared HCPCS/NOC codes
    Transplant review — submission and routing
    Transplant review routingPreauthorization requests for products marked '††' will be reviewed by the Humana National Transplant Network
    Submission channelsRequests can be submitted by fax to 502-508-9300, by phone at 866-421-5663 (Mon–Fri, 7 a.m.–7 p.m. Central), or by email to transplant@humana.com
    ScopeApplies to transplant-related products and certain cell therapies noted in the medication list
    Annotation key
    Annotation legend'*' = New preauthorization requirement; '†' = New-to-market drug; '‡' = HCPCS/NOC codes require NDC on claims; '**' = Step therapy required; '††' = Reviewed by Humana National Transplant Network
    Where usedThese annotations appear in the medication PA/notification list to indicate special handling or requirements
    PurposeHelps providers identify new requirements, billing requirements, step therapy, and transplant routing at-a-glance